Target intelligence / Profile preview

Cholera toxin subunit B (CTB)

Target
CTB
Molecular classification
Other (Bacterial toxin subunit), Lectin-like protein, Subunit of AB5 toxin
01

Overview

Cholera toxin subunit B is the pentameric receptor-binding component of the AB5 holotoxin produced by Vibrio cholerae. Each B subunit (∼11 kDa) forms a doughnut-shaped pentamer that binds specifically and with high affinity to GM1 ganglioside receptors on the surface of intestinal epithelial cells[2][5]. This binding is necessary for the uptake and retrograde transport of the toxic A subunit, ultimately leading to the characteristic increase in cAMP and secretory diarrhea of cholera. CTB alone is non-toxic (lacking enzymatic activity), but it is highly immunogenic and has been widely used as a mucosal immune response stimulator, research tool for membrane trafficking, and as a carrier protein in chimeric vaccine development[1][4]. GM1 binding capacity and pentameric assembly are critical for its biological function[2].

Other names
Cholera enterotoxin subunit BCholera toxin B subunitCTB
02

Mechanism of action

Binds with high specificity to GM1 ganglioside on intestinal epithelial cells; mediates endocytosis and retrograde trafficking of the A subunit, enabling delivery of cytotoxic component[2][5]

03

Biological functions

Cell bindingToxin deliveryImmune response stimulation (as carrier)Facilitates endocytosis and retrograde trafficking
04

Disease associations

Infection (role in cholera infection)Other (tool in membrane biology, mucosal immunology, vaccine research)
05

Safety considerations

Immunogenicitypotential off-target immune activation when used as a vaccine carrier or mucosal adjuvant
06

Interacting drugs

None in clinical use as a direct target, but used as a carrier/adjuvant in vaccine formulations
07

Biomarkers

None established for patient selection/monitoring; GM1 ganglioside presence is used laboratory-wise for binding assays

Beyond the preview

Go deeper on Cholera toxin subunit B (CTB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cholera toxin subunit B (CTB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call